Nephrology

Latest News

Combined SGLT2i and GLP-1 RA Therapy Provides Complementary Cardiorenal Protection
Combined SGLT2i and GLP-1 RA Therapy Provides Complementary Cardiorenal Protection, According to Comprehensive Meta-Analysis

July 12th 2024

Findings from the large meta-analysis provide strong support for use of both classes to reduce CV and renal disease in adults with type 2 diabetes.

George L Bakris, MD, Expert in Hypertension and Metabolic Disease, Has Died / image courtesy of University of Chicago
George L Bakris, MD, Expert in Hypertension and Metabolic Disease, Has Died

June 20th 2024

Semaglutide: GLP-1 Mimetic Significantly Reduces Risk of Renal Events, MACE, Mortality in People with CKD, T2D ©Peter Hansen/stock.adobe.com
Semaglutide Significantly Reduces Risk of Renal Events, MACE, Mortality in People with CKD, T2D in Final FLOW Trial Findings

May 24th 2024

Cardiovascular-Kidney-Metabolic (CMK) Syndrome Affects Nearly All US Adults
Cardiovascular-Kidney-Metabolic (CKM) Syndrome Affects Nearly All US Adults

April 30th 2024

Latest CME Events & Activities

Expert Illustrations and Commentaries™: Emerging Therapies and Treatment Strategies to Improve Care for Your Patients with Anemia in CKD

View More

The Nephrology Nurse’s Role in Optimizing Outcomes for Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Advances In™: Targeting PSMA to Advance Diagnosis And Management Of Patients With Prostate Cancer

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?

View More

Community Practice Connections: 7th Annual School of Nursing Oncology™

View More

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

GU Tumor Board®: Real World Strategies to Inform Individualized Care in Renal Cell Carcinoma

View More

Medical Crossfire®: Optimizing Care for Patients With Anemia and Chronic Kidney Disease

View More

Show Me Your Care Plan!™: Nurses on the Forefront of Patient Care, Communication, and Education in Prostate Cancer

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

More News

© 2024 MJH Life Sciences

All rights reserved.